CoChat

Regulatory dynamics of arginine metabolism in Staphylococcus aureus

Reslane, Itidal, Watson, Gabrielle F., Handke, Luke D., Fey, Paul D. · 2024 · Biochemical Society Transactions
Cited by 16

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Staphylococcus aureus is a highly significant pathogen with several well studied and defined virulence factors. However, the metabolic pathways that are required to facilitate infection are not well described. Previous data have documented that S. aureus requires glucose catabolism during initial stages of infection. Therefore, certain nutrients whose biosynthetic pathway is under carbon catabolite repression and CcpA, including arginine, must be acquired from the host. However, even though S. aureus encodes pathways to synthesize arginine, biosynthesis of arginine is repressed even in the absence of glucose. Why is S. aureus a functional arginine auxotroph? This review discusses recently described regulatory mechanisms that are linked to repression of arginine biosynthesis using either proline or glutamate as substrates. In addition, recent studies are discussed that shed insight into the ultimate mechanisms linking arginine auxotrophy and infection persistence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bst20240710

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 82

  1. 2018, Staphylococcus aureus nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections, Front. Microbiol., 9, 2419, 10.3389/fmicb.2018.02419 · DOI · Paper page
  2. 1997, Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks, Clin. Microbiol. Rev., 10, 505, 10.1128/CMR.10.3.505 · DOI · Paper page
  3. 2001, Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group, N. Engl. J. Med., 344, 11, 10.1056/NEJM200101043440102 · DOI · Paper page
  4. 2015, Risk factors for methicillin-resistant Staphylococcus aureus skin and soft-tissue infections in outpatients in Taiwan, Epidemiol. Infect., 143, 749, 10.1017/S0950268814001642 · DOI
  5. 2012, Recurrent furunculosis: a review of the literature, Br. J. Dermatol., 167, 725, 10.1111/j.1365-2133.2012.11151.x · DOI
  6. 2015, Pathogenesis of Staphylococcus aureus abscesses, Am. J. Pathol., 185, 1518, 10.1016/j.ajpath.2014.11.030 · DOI · Paper page
  7. 2010, Community-associated meticillin-resistant Staphylococcus aureus, Lancet, 375, 1557, 10.1016/S0140-6736(09)61999-1 · DOI · Paper page
  8. 2016, Expanded glucose import capability affords Staphylococcus aureus optimized glycolytic flux during infection, mBio, 7, e00296-16, 10.1128/mBio.00296-16 · DOI · Paper page
  9. 2015, Glycolytic dependency of high-level nitric oxide resistance and virulence in Staphylococcus aureus, mBio, 6, e00045-15, 10.1128/mBio.00045-15 · DOI · Paper page
  10. 1996, Proline is biosynthesized from arginine in Staphylococcus aureus, Microbiology (Reading), 142, 1491, 10.1099/13500872-142-6-1491 · DOI
  11. 2010, Ccpa mediates proline auxotrophy and is required for Staphylococcus aureus pathogenesis, J. Bacteriol., 192, 3883, 10.1128/JB.00237-10 · DOI · Paper page
  12. 2023, Proline transporters ProT and PutP are required for Staphylococcus aureus infection, PLoS Pathog., 19, e1011098, 10.1371/journal.ppat.1011098 · DOI
  13. 2024, Staphylococcus aureus adapts to exploit collagen-derived proline during chronic infection, Nat. Microbiol., 9, 2506, 10.1038/s41564-024-01769-9 · DOI
  14. 2016, Regulatory requirements for Staphylococcus aureus nitric oxide resistance, J. Bacteriol., 198, 2043, 10.1128/JB.00229-16 · DOI · Paper page
  15. 2021, The intersection of the Staphylococcus aureus Rex and SrrAB regulons: an example of metabolic evolution that maximizes resistance to immune radicals, mBio, 12, e0218821, 10.1128/mBio.02188-21 · DOI
  16. 2018, Peroxisome proliferator-activated receptor γ is essential for the resolution of Staphylococcus aureus skin infections, Cell Host Microbe, 24, 261, 10.1016/j.chom.2018.07.001 · DOI · Paper page
  17. 2016, Staphylococcus aureus lactate- and malate-quinone oxidoreductases contribute to nitric oxide resistance and virulence, Mol. Microbiol., 100, 759, 10.1111/mmi.13347 · DOI · Paper page
  18. 2019, Protease-mediated growth of Staphylococcus aureus on host proteins is opp3 dependent, mBio, 10, e02553-18, 10.1128/mBio.02553-18 · DOI
  19. 2012, CcpA regulates arginine biosynthesis in Staphylococcus aureus through repression of proline catabolism, PLoS Pathog., 8, e1003033, 10.1371/journal.ppat.1003033 · DOI · Paper page
  20. 1975, Amino acid requirements of staphylococci isolated from human skin, Can. J. Microbiol., 21, 729, 10.1139/m75-107 · DOI · Paper page
  21. 1979, The nature of arginine auxotrophy in cutaneous populations of staphylococci, J. Gen. Microbiol., 110, 305, 10.1099/00221287-110-2-305 · DOI
  22. 1937, The nutrition of staphylococcus aureus ;nitrogen requirements, Br. J. Exp. Pathol., 18, 322
  23. 2006, Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus, Lancet, 367, 731, 10.1016/S0140-6736(06)68231-7 · DOI · Paper page
  24. 2022, Catabolic ornithine carbamoyltransferase activity facilitates growth of Staphylococcus aureus in defined medium lacking glucose and arginine, mBio, 13, e0039522, 10.1128/mbio.00395-22 · DOI
  25. 2022, Staphylococcus aureus does not synthesize arginine from proline under physiological conditions, J. Bacteriol., 204, e0001822, 10.1128/jb.00018-22 · DOI
  26. 2014, Nutrient limitation governs Staphylococcus aureus metabolism and niche adaptation in the human nose, PLoS Pathog., 10, e1003862, 10.1371/journal.ppat.1003862 · DOI · Paper page
  27. 2017, The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota, Nat. Rev. Microbiol., 15, 675, 10.1038/nrmicro.2017.104 · DOI · Paper page
  28. 2016, Experimental evolution of metabolic dependency in bacteria, PLoS Genet., 12, e1006364, 10.1371/journal.pgen.1006364 · DOI · Paper page
  29. 2021, Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis, Nat. Rev. Microbiol., 19, 331, 10.1038/s41579-020-00477-5 · DOI · Paper page
  30. 2015, Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis, Nat. Genet., 47, 57, 10.1038/ng.3148 · DOI · Paper page
  31. 2018, Convergent metabolic specialization through distinct evolutionary paths in Pseudomonas aeruginosa, mBio, 9, e00269-18, 10.1128/mBio.00269-18 · DOI
  32. 1995, Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis, J. Clin. Microbiol., 33, 37, 10.1128/jcm.33.1.37-40.1995 · DOI · Paper page
  33. 1996, The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa, J. Med. Microbiol., 45, 110, 10.1099/00222615-45-2-110 · DOI · Paper page
  34. 2024, Restriction of arginine induces antibiotic tolerance in Staphylococcus aureus, Nat. Commun., 15, 6734, 10.1038/s41467-024-51144-9 · DOI
  35. 1986, Biosynthesis and metabolism of arginine in bacteria, Microbiol. Rev., 50, 314, 10.1128/mr.50.3.314-352.1986 · doi:10.1128/mr.50.3.314-352.1986 · Paper page
  36. 2004, Biosynthesis of arginine and polyamines, EcoSal Plus, 1, 10.1128/ecosalplus.3.6.1.10 · DOI
  37. 1963, Acetylated intermediates of arginine synthesis in Bacillus subtilis, Biochim. Biophys. Acta, 69, 174, 10.1016/0006-3002(63)91241-1 · doi:10.1016/0006-3002(63)91241-1
  38. 2019, Regulation of arginine biosynthesis, catabolism and transport in Escherichia coli, Amino Acids, 51, 1103, 10.1007/s00726-019-02757-8 · DOI
  39. 2016, Staphylococcus aureus transcriptome architecture: from laboratory to infection-mimicking conditions, PLoS Genet., 12, e1005962, 10.1371/journal.pgen.1005962 · DOI · Paper page
  40. 2024, Glutamate-dependent arginine biosynthesis requires the inactivation of spoVG, sarA, and ahrC in Staphylococcus aureus, J. Bacteriol., 206, e0033723, 10.1128/jb.00337-23 · DOI
  41. 2011, Papain-like proteases of Staphylococcus aureus, Adv. Exp. Med. Biol., 712, 1, 10.1007/978-1-4419-8414-2_1 · DOI
  42. 2011, Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus, Microbiology, 157, 786, 10.1099/mic.0.044503-0 · DOI · Paper page
  43. 2001, Description of staphylococcus serine protease (ssp) operon in Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine protease, Infect. Immun., 69, 159, 10.1128/IAI.69.1.159-169.2001 · DOI · Paper page
  44. 2004, The role and regulation of the extracellular proteases of Staphylococcus aureus, Microbiology, 150, 217, 10.1099/mic.0.26634-0 · DOI · Paper page
  45. 1995, Protein kinase-dependent HPr/CcpA interaction links glycolytic activity to carbon catabolite repression in gram-positive bacteria, Mol. Microbiol., 15, 1049, 10.1111/j.1365-2958.1995.tb02280.x · DOI · Paper page
  46. 1995, Catabolite repression in Bacillus subtilis: a global regulatory mechanism for the gram-positive bacteria?, Mol. Microbiol., 15, 395, 10.1111/j.1365-2958.1995.tb02252.x · DOI · Paper page
  47. 2003, CcpA-dependent carbon catabolite repression in bacteria, Microbiol. Mol. Biol. Rev., 67, 475, 10.1128/MMBR.67.4.475-490.2003 · DOI · Paper page
  48. 2008, The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus, J. Infect. Dis., 197, 1523, 10.1086/587907 · DOI · Paper page
  49. 1997, DNA binding of Escherichia coli arginine repressor mutants altered in oligomeric state, Mol. Microbiol., 24, 1143, 10.1046/j.1365-2958.1997.4301791.x · DOI
  50. 2004, Argr and AhrC are both required for regulation of arginine metabolism in Lactococcus lactis, J. Bacteriol., 186, 1147, 10.1128/JB.186.4.1147-1157.2004 · DOI
  51. 1992, Characterization of the arginine repressor from Salmonella typhimurium and its interactions with the carAB operator, J. Mol. Biol., 225, 11, 10.1016/0022-2836(92)91022-H · DOI
  52. 2004, Transcriptome analysis of the ArgR regulon in Pseudomonas aeruginosa, J. Bacteriol., 186, 3855, 10.1128/JB.186.12.3855-3861.2004 · DOI · Paper page
  53. 1992, Purification and initial characterization of AhrC: the regulator of arginine metabolism genes in Bacillus subtilis, Mol. Microbiol., 6, 267, 10.1111/j.1365-2958.1992.tb02008.x · doi:10.1111/j.1365-2958.1992.tb02008.x
  54. 2002, The structure of AhrC, the arginine repressor/activator protein from Bacillus subtilis, Acta Crystallogr. D Biol. Crystallogr., 58, 421, 10.1107/S0907444901021692 · doi:10.1107/s0907444901021692
  55. 2008, Structure and function of the arginine repressor-operator complex from Bacillus subtilis, J. Mol. Biol., 379, 284, 10.1016/j.jmb.2008.03.007 · DOI
  56. 1989, Nucleotide sequence of a Bacillus subtilis arginine regulatory gene and homology of its product to the Escherichia coli arginine repressor, Gene, 80, 29, 10.1016/0378-1119(89)90247-3 · doi:10.1016/0378-1119(89)90247-3
  57. 2007, Structure of the C-terminal effector-binding domain of AhrC bound to its corepressor L-arginine, Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun., 63, 918, 10.1107/S1744309107049391 · doi:10.1107/s1744309107049391
  58. 2007, A high-resolution structure of the DNA-binding domain of AhrC, the arginine repressor/activator protein from Bacillus subtilis, Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun., 63, 914, 10.1107/S1744309107048166 · doi:10.1107/s1744309107048166
  59. 1997, Operator interactions by the Bacillus subtilis arginine repressor/activator, AhrC: novel positioning and DNA-mediated assembly of a transcriptional activator at catabolic sites, Mol. Microbiol., 26, 37, 10.1046/j.1365-2958.1997.5441907.x · doi:10.1046/j.1365-2958.1997.5441907.x
  60. 1994, Explanation for different types of regulation of arginine biosynthesis in Escherichia coli B and Escherichia coli K12 caused by a difference between their arginine repressors, J. Mol. Biol., 235, 221, 10.1016/S0022-2836(05)80028-2 · DOI
  61. 2018, Repression of branched-chain amino acid synthesis in Staphylococcus aureus is mediated by isoleucine via CodY, and by a leucine-rich attenuator peptide, PLoS Genet., 14, e1007159, 10.1371/journal.pgen.1007159 · DOI · Paper page
  62. 1988, Role of the arginine deiminase system in protecting oral bacteria and an enzymatic basis for acid tolerance, Appl. Environ. Microbiol., 54, 1318, 10.1128/aem.54.6.1318-1324.1988 · DOI · Paper page
  63. 2004, Characterization of the arginine deiminase operon of Streptococcus rattus FA-1, Appl. Environ. Microbiol., 70, 1321, 10.1128/AEM.70.3.1321-1327.2004 · DOI
  64. 2014, Arginine deiminase in Staphylococcus epidermidis functions to augment biofilm maturation through pH homeostasis, J. Bacteriol., 196, 2277, 10.1128/JB.00051-14 · DOI · Paper page
  65. 1998, The arcABDC gene cluster, encoding the arginine deiminase pathway of Bacillus licheniformis, and its activation by the arginine repressor argR, J. Bacteriol., 180, 6468, 10.1128/JB.180.24.6468-6475.1998 · DOI · Paper page
  66. Sonenshein, 1993, Bacillus subtilis and Other Gram-Positive Bacteria: Biochemistry, Physiology, and Molecular Genetics, 10.1128/9781555818388 · DOI
  67. 2015, Evolution of proline biosynthesis: enzymology, bioinformatics, genetics, and transcriptional regulation, Biol. Rev. Camb. Philos. Soc., 90, 1065, 10.1111/brv.12146 · DOI · Paper page
  68. 2018, Staphylococcus aureus infection dynamics, PLoS Pathog., 14, e1007112, 10.1371/journal.ppat.1007112 · DOI · Paper page
  69. 2019, Peritoneal GATA6+ macrophages function as a portal for Staphylococcus aureus dissemination, J. Clin. Invest., 129, 4643, 10.1172/JCI127286 · DOI · Paper page
  70. 2010, Contribution of coagulases towards Staphylococcus aureus disease and protective immunity, PLoS Pathog., 6, e1001036, 10.1371/journal.ppat.1001036 · DOI · Paper page
  71. 2018, Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia, Genome Med., 10, 65, 10.1186/s13073-018-0574-x · DOI · Paper page
  72. 2009, Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus, Infect. Genet. Evol., 9, 32, 10.1016/j.meegid.2008.09.012 · DOI · Paper page
  73. 2017, Severe infections emerge from commensal bacteria by adaptive evolution, Elife, 6, e30637, 10.7554/eLife.30637 · DOI · Paper page
  74. 2022, Niche-specific genome degradation and convergent evolution shaping Staphylococcus aureus adaptation during severe infections, Elife, 11, e77195, 10.7554/eLife.77195 · DOI
  75. 2011, Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR, PLoS Pathog., 7, e1002359, 10.1371/journal.ppat.1002359 · DOI · Paper page
  76. 2021, Clinically relevant mutations in core metabolic genes confer antibiotic resistance, Science, 371, eaba0862, 10.1126/science.aba0862 · DOI · Paper page
  77. 2022, Convergent evolution of antibiotic tolerance in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia, Infect. Immun., 90, e0000122, 10.1128/iai.00001-22 · DOI
  78. 2015, IL-12 promotes myeloid-derived suppressor cell recruitment and bacterial persistence during Staphylococcus aureus orthopedic implant infection, J. Immunol., 194, 3861, 10.4049/jimmunol.1402689 · DOI · Paper page
  79. 2014, Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection, J. Immunol., 192, 3778, 10.4049/jimmunol.1303408 · DOI · Paper page
  80. 2013, Targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infections, J. Immunol., 190, 2159, 10.4049/jimmunol.1202348 · DOI · Paper page
  81. 2018, Arginase-1 expression in myeloid cells regulates Staphylococcus aureus planktonic but not biofilm infection, Infect. Immun., 86, e00206-18, 10.1128/IAI.00206-18 · DOI
  82. 2011, Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function, Trends Immunol., 32, 19, 10.1016/j.it.2010.10.002 · DOI · Paper page

Cited by

See all 16

Metadata

Authors
Reslane, I., Watson, G. F., Handke, L. D., & Fey, P. D.
Affiliations
Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, U.S.A.
Venue
Biochemical Society Transactions
Published
2024-12-10
Volume
52
Issue
6
Pages
2513-2523
ISSN
  • 0300-5127
  • 1470-8752
Cited by
16
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.